Chris Holsinger

Biography

Dr. Holsinger is Professor and Chief of Head and Neck Surgery at Stanford University Medical Center, where he also leads the multidisciplinary Head and Neck Oncology Program at the Stanford Cancer Center. From 2003-2013, Dr. Holsinger worked at the Department of Head and Neck Surgery at the University of Texas M.D. Anderson Cancer Center where he founded and led the Program in Minimally Invasive and Endoscopic Head and Neck Surgery and co-directed the program in Minimally Invasive Technology in Oncologic Surgery. Dr. Holsinger’s surgical practice focuses on the surgical management of benign and malignant diseases of the thyroid, as well as head and neck cancer. His areas of research interest include endoscopic head and neck surgery, including transoral robotic surgery and transoral laser microsurgery, as well as time-honoured approaches of conservation laryngeal surgery, supracricoid partial laryngectomy. Dr. Holsinger's research focuses on surgical innovation and clinical trials through NCI-funded cooperative groups. He serves as surgical PI for RTOG920 and coordinates surgeon-credentialing for ECOG 3311, a prospective clinical trial to study robotic head and neck surgery. He leads an investigator-device-exemption trial to evaluate the safety and efficacy of a next-generation flexible robotic surgical system. In 2014, he began a prospective clinical trial to evaluate multispectral imaging of patients with oropharyngeal cancer, in an effort to discern tumor from tumor. Currently, he leads a study to evaluate hyper-spectral imaging to improve surgical vision.

Research Interest

Surgical management of benign and malignant diseases of the thyroid, parathyroid and head and neck.